PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.01%
Share change of 0.01% while 1177.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.01%
Diluted share change of 0.01% while 1177.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth under 50% of 1177.HK's 110.13%. Michael Burry might suspect questionable revenue recognition or rising costs.
0.00%
FCF growth under 50% of 1177.HK's 273.01%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
-10.66%
Negative 5Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-12.96%
Negative 3Y CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
112.73%
OCF/share CAGR of 112.73% while 1177.HK is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-55.74%
Negative 3Y OCF/share CAGR while 1177.HK stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
-310.85%
Negative 5Y net income/share CAGR while 1177.HK is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-154.89%
Negative 3Y CAGR while 1177.HK is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while 1177.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.